ASX 50

David Berthon-Jones and Garry Laurence said to look for dividends or growth elsewhere as CBA is the world's most expensive bank stock.

Plasma is still a winner for the healthcare giant, but vaccinations face hurdles.

These 10 stocks will take short sellers the most days to cover positions and are most likely to sink or surge on earnings this month.

February earnings season is here, and it could be make or break for beaten down stocks in the ASX Energy sector like Woodside and Santos.

Bears can beat the bulls with growth and yield

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.

Mr Hogan labelled inflation "the biggest strategic threat to the economy" and said the RBA has insufficient evidence it's contained.

We spoke with Brandywine Global to find out where they're seeing value around the world and why they own global airlines.

Copper’s strong run in face of trade wars piques investor interest in stocks such as Develop, discovery runaway AusQuest, Coda and Noronex.

Traders are waiting for weeks to withdraw gold in London, as demand for physical gold ramps up to several new factors.

First Sentier's David Wilson and Elston's Joe McCarthy pick apart companies with strong sales growth - is it all it's cracked up to be?

How should investors interpret Trump’s tariff threats—literally, seriously, neither, or both?

Corporate Australia has battled (too) many headwinds over the past three years, but investor optimism is on the rise for better times ahead.

BNPL has its roots in the 19th century, originating from instalment plans that allowed consumers to purchase expensive items like furniture and farm equipment by...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future...

Amid the DeepSeek-induced selloff, REITs were amongst the better performing sectors. But what will the developments mean for data centres?

Could this Australian-American healthcare stalwart hit $60/share?

Russia's invasion of Ukraine has untethered gold's correlation to real interest rates and threatens to extend an ongoing bull run.

Joe McCarthy from Elston and David Wilson from First Sentier run the ruler over your most-tipped growth stocks for 2025

We discuss our stock picks from 2024 and then highlight three new high-quality companies best placed to navigate 2025.

Pilbara Minerals shares are rallying on a better-than-expected quarterly production and activities report, we investigate why.

In this analysis piece, we examine whether DeepSeek's news is a blip or a game-changer for the ultra-bull market in mega-cap tech.

Rudi Filapek-Vandyck, Michael Wayne, and Henry Jennings each boldly nominate the one ASX stock they believe will hit $500 first.

Opportunities emerge as China shifts gears, banks face valuation pressure, and real asset M&A heats up amid an indexing frenzy